Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-15-072638

Options or other derivatives

  • Chief Financial Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NIFFENEGGER KATHI · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-12-22 Grant or award : show line 1 in the form Share Option (Right to Buy) +10,000 10,000 D
Loading xslF345X03/v427688_4.xml…